The global blood cancers testing market is exhibiting significant expansion, propelled by a rising occurrence of myeloma and other related diseases. Researchers estimate the current market value to be substantial, with projections indicating a steady compound annual increase rate (CAGR) over the coming period. Key factors shaping the industry inclu